News

Filter

US FDA approves J&J’s psoriasis drug Stelara and Allos’ cancer agent Folotyn

28-09-2009

After lengthy deliberations, the US Food and Drug Administration has finally approved Johnson & Johnson…

Abbott LaboratoriesadalimumabAmgenEnbreletanerceptFolotynHumiraImmunologicalsJohnson & JohnsonNorth AmericaOncologyPharmaceuticalPralatrexate Solution for Intravenous InjectiStelara Injectionustekinumab

Back to top